Aortic Valve Update & Structural Disease

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Who Is a TAVR Candidate in 2016?

The assessment of risk and patient selection.

By Robert P. Gooley, MBBS (Hons), and Ian T. Meredith, MBBS (Hons), PhD

CoreValve Evolut R in Current TAVR Practice

How the newest iteration of this self-expanding technology fits into the United States TAVR landscape.

By Abdul Moiz Hafiz, MD, and Duane Pinto, MD, MPH

The Sapien 3 Valve

Current use in United States TAVR practice.

By Ramin S. Hastings, MD, and Isaac George, MD

New TAVR Devices: European Experience and Status of US Trials

An overview of the design features and data related to three next-generation valve systems.

By Brandon M. Jones, MD, and Amar Krishnaswamy, MD

The Next Wave of LAA Occlusion Technologies

Interventional stroke prevention in patients with atrial fibrillation.

By Martin W. Bergmann, MD, FESC

Transcatheter Closure of Atrial Septal Defects

An update on ASD occlusion devices.

By Victor-Xavier Tadros, MD, MSc, and Anita W. Asgar, MD, FRCPC, FACC

What's Missing From the Triple Aim of Health Care?

It's time to prioritize worker satisfaction, along with the aims of patient experience, population health, and cost reduction.

By Larry Sobal, MBA, MHA, CMPE, and Suzette Jaskie

A Comparison of Internal and External Peer Review

An institution's insights into the advantages and disadvantages of a peer review process to evaluate cardiac catheterization laboratories.

By Donald R. Lilly, MD, and Stephen A. Lewis, MD

Should all aortic stenosis patients older than 80 years undergo TAVR rather than SAVR?

With Gregory Mishkel, MD, FRCPC, FACC, FSCAI; Vikas Aggarwal, MD, FACC; Paul J. Pearson, MD, PhD; Vinod H. Thourani, MD, FACC, FACS; Jessica Forcillo, MD, MSc, FRCSC; and Nicolas M. Van Mieghem, MD, PhD, FESC

Innovations

An Interview With Christopher J. White, MD

Dr. White discusses regulatory issues, fellowship training, and the evolving role of interventional cardiologists.